title: Efficiency of once-weekly subcutaneous administration of recombinant human erythropoietin versus three times a week administration in hemodialysis patients.
authors.forename: M
authors.initials: M
authors.lastname: Lago
authors.forename: R
authors.initials: R
authors.lastname: Pérez-García
authors.forename: M S
authors.initials: MS
authors.lastname: García de Vinuesa
authors.forename: F
authors.initials: F
authors.lastname: Anaya
authors.forename: F
authors.initials: F
authors.lastname: Valderrábano
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D004921:Erythropoietin / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin